Hopes and Questions raised by Alzheimer’s drug Leqembi (lecanemab)
The FDA has accepted Leqembi, the primary disease-modifying deal withment for early-stage Alzheimer’s and a precursor condition, gentle cognitive impairment....
raised
The FDA has accepted Leqembi, the primary disease-modifying deal withment for early-stage Alzheimer’s and a precursor condition, gentle cognitive impairment....
